Background
Methods
Human studies
Ethical statements
Study design
CT protocol
CT scan analyses
Animal experiments
Statistical analysis
Results
Study patients
Patient number | Etiology | Comorbidity | IBW (kg) | ARDS onset (h) | FiO2 (%) | PaO2/FiO2 (mmHg) | PEEP (cmH2O) | Tidal volume (mL/kg IBW) | Compliance (mL.cmH2O-1) | Pplat (cmH2O) | ARDS phenotype |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Infectious Pneumonia | Acute leukemia | 63 | 18 | 50 | 154 | 8 | 7.6 | 20 | 33 | NF |
2 | Infectious Pneumonia | Myelofibrosis | 70 | 6 | 100 | 127 | 16 | 5.9 | 25 | 33 | NF |
3 | Infectious Pneumonia | Acute leukemia | 55 | 24 | 70 | 109 | 18 | 5.8 | 21 | 33 | NF |
4 | Infectious Pneumonia | 47 | 4 | 100 | 75 | 12 | 5.7 | 13 | 28 | NF | |
5 | Infectious Pneumonia | Acute leukemia | 54 | 10 | 60 | 145 | 13 | 6.3 | 18 | 31 | NF |
6 | Aspiration | Cardiac arrest | 73 | 4 | 100 | 50 | 12 | 5 .8 | 17 | 30 | NF |
7 | Aspiration | Gastrectomy | 77 | 12 | 100 | 80 | 18 | 5.5 | 20 | 28 | NF |
8 | Viral pneumonia | 64 | 6 | 70 | 113 | 20 | 7.4 | 18 | 32 | NF | |
Median | 63.5 | 8.0 | 85 | 111 | 14.5 | 5.9 | 19.0 | 31.5 | |||
IQR | (55.0–70.8) | (5.5–13.5) | (68–100) | (79–132) | (12.0–18.0) | (5.8–6.6) | (17.8–20.3) | (29.5–33.0) |